The Pre-Synaptic Blocker Toosendanin Does Not Inhibit Secretion in Exocrine Cells

ZJ Cui,XH He
DOI: https://doi.org/10.3748/wjg.v8.i5.918
IF: 5.374
2002-01-01
World Journal of Gastroenterology
Abstract:AIM: Toosendanin is a pre-synaptic blocker at the neuromuscular junction and its inhibitory effect is divided into an initial facilitative/stimulatory phase followed by a prolonged inhibitory phase. The present study investigated whether the subsequent inhibitory phase was due to exhaustion of the secretory machinery as a result of extensive stimulation during the initial facilitative phase. More specifically, this paper examined whether toosendanin could directly inhibit the secretory machinery in exocrine cells.METHODS: Rat pancreatic acinar cells were isolated by collagenase digestion. Secretion was assessed by measuring the amount of amylase released into the extracellular medium as a percentage of the total present in the cells before stimulation. Cholecystokinin (CCK)-induced increases in intracellular calcium in single cells were measured with fura-2 microfluorometry.RESULTS: Effects of toosendanin on CCK-induced amylase secretion and calcium oscillations were investigated. Toosendanin of 87-870 muM had no effect on 10 pM-100 nM CCK-stimulated amylase secretion, nor did 8.7-870 muM toosendanin inhibit 5 pM CCK-induced calcium oscillations. In contrast, 10 nM CCK, receptor antagonist FK 480 completely blocked 5 pM CCK-induced calcium oscillations.CONCLUSION: The pre-synaptic "blocker" toolsendanin is a selective activator of the voltage-dependent calcium channels, but does not interfere with the secretory machinery itself.
What problem does this paper attempt to address?